Profilo
Jane Buus Laursen is currently Director at Stayble Therapeutics AB since 2018.
Formerly, Corporate VP-Global Business Development at Novo Nordisk A. Education includes doctorates from the University of Kansas and the Technical University of Denmark.
Posizioni attive di Jane Buus Laursen
| Società | Posizione | Inizio |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Direttore/Membro del Consiglio | 01/01/2018 |
| CAMURUS AB | Corporate Officer/Principal | 23/03/2026 |
Precedenti posizioni note di Jane Buus Laursen
| Società | Posizione | Fine |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formazione di Jane Buus Laursen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
















